← Leaderboards
Maria F Braga
Henry M. Jackson Fdn For The Adv Mil/Med
$9,568,954
Attributed
$9,568,954
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $913.9K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,568,954 · 4
By mechanism
U01$8,825,072 · 3
R21$743,882 · 1
Top collaborators
No co-investigators on record.
Most similar at Henry M. Jackson Fdn For The Adv Mil/Med
Same institution · by research overlap
- Ramona E. Von Leden$150,263
Others in their field
Top investigators on “Soman”
- Pamela J Lein · University Of California At Davis$11,637,025
- Doodipala Samba Reddy · North Carolina State University Raleigh$10,245,425
- Michael A. Rogawski · Neurological Disorders And Stroke$6,607,503
- Thimmasettappa Thippeswamy · Iowa State University$5,622,241
- Edson X Albuquerque · University Of Maryland Baltimore$4,917,138
- Manisha N Patel · National Jewish Health$4,313,565
Research focus
SomanBrain InjuriesNerve AgentSeizuresBehavioralAnticonvulsantsCessation Of LifeNeuropathologyRattusPreventExposure ToToxic EffectAcuteAmygdaloid StructureNeuron LossAdultStatus EpilepticusLeadMaleNerve DegenerationFemaleMedicalBrain RegionChemical Weapons
Grant awards (19)
Antiglutamatergic Therapy to Protect the Brain Against Nerve Agents$721,888
U01 · FY2025 · NS · contact PI
Antiglutamatergic Therapy to Protect the Brain Against Nerve Agents$735,815
U01 · FY2024 · NS · contact PI
Antiglutamatergic Therapy to Protect the Brain Against Nerve Agents$749,343
U01 · FY2023 · NS · contact PI
Antiglutamatergic Therapy to Protect the Brain Against Nerve Agents$762,477
U01 · FY2022 · NS · contact PI
Antiglutamatergic Therapy to Protect the Immature Brain Against Nerve Agents$449,535
U01 · FY2020 · NS · contact PI
Antiglutamatergic Therapy to Protect the Immature Brain Against Nerve Agents$449,618
U01 · FY2019 · NS · contact PI
Antiglutamatergic Therapy to Protect the Immature Brain Against Nerve Agents$449,430
U01 · FY2018 · NS · contact PI
Targeting the Glutamatergic System to Counteract Soman Toxicity in Immature Rats$371,941
R21 · FY2016 · NS · contact PI
Efficacy of GluR5 Antogonists Against Soman-Induced Seizures and Neuropathology$153,979
U01 · FY2016 · NS · contact PI
Efficacy of GluR5 Antogonists Against Soman-Induced Seizures and Neuropathology$541,966
U01 · FY2015 · NS · contact PI
Targeting the Glutamatergic System to Counteract Soman Toxicity in Immature Rats$371,941
R21 · FY2015 · NS · contact PI
Efficacy of GluR5 Antogonists Against Soman-Induced Seizures and Neuropathology$537,783
U01 · FY2014 · NS · contact PI
Efficacy of GluR5 Antogonists Against Soman-Induced Seizures and Neuropathology$533,799
U01 · FY2013 · NS · contact PI
Efficacy of GluR5 Antogonists Against Soman-Induced Seizures and Neuropathology$530,006
U01 · FY2012 · NS · contact PI
Efficacy of GluR5 Antogonists Against Soman-Induced Seizures and Neuropathology$526,392
U01 · FY2011 · NS · contact PI
Efficacy of GluR5 Antogonists Against Soman-Induced Seizures and Neuropathology$432,256
U01 · FY2009 · NS · contact PI
Efficacy of GluR5 Antogonists Against Soman-Induced Seizures and Neuropathology$419,668
U01 · FY2008 · NS · contact PI
Efficacy of GluR5 Antogonists Against Soman-Induced Seizures and Neuropathology$407,447
U01 · FY2007 · NS · contact PI
Efficacy of GluR5 Antogonists Against Soman-Induced Seizures and Neuropathology$423,670
U01 · FY2006 · NS · contact PI